MedPath

陕西必康制药集团控股有限公司

Ownership
-
Established
1997-01-06
Employees
-
Market Cap
-
Website
http://www.sxbicon.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

71

NMPA:71

Drug Approvals

复方大青叶合剂

Approval Number
国药准字Z61021325
Approval Date
Dec 16, 2020
NMPA

小儿化痰止咳颗粒

Approval Number
国药准字Z61021447
Approval Date
Dec 16, 2020
NMPA

补肾强身胶囊

Approval Number
国药准字Z20003285
Approval Date
Dec 16, 2020
NMPA

五味子颗粒

Approval Number
国药准字Z61021446
Approval Date
Dec 16, 2020
NMPA

银翘解毒合剂

Approval Number
国药准字Z61021327
Approval Date
Dec 16, 2020
NMPA

安胃胶囊

Approval Number
国药准字Z20003284
Approval Date
Dec 16, 2020
NMPA

银翘解毒颗粒

Approval Number
国药准字Z61021448
Approval Date
Oct 27, 2020
NMPA

风痛宁片

Approval Number
国药准字Z61021443
Approval Date
Oct 27, 2020
NMPA

小儿感冒颗粒

Approval Number
国药准字Z61021211
Approval Date
Oct 27, 2020
NMPA

感冒清热颗粒

Approval Number
国药准字Z61021207
Approval Date
Oct 27, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.